Sign Up to like & get
recommendations!
0
Published in 2018 at "Analytical biochemistry"
DOI: 10.1016/j.ab.2018.06.025
Abstract: A novel and rapid method to determine the potency of inhibitors for tryptophan 2, 3-dioxygenase (TDO2) activities in human and preclinical species was successfully developed and validated utilizing LC-MS/MS. Previously reported TDO2 activity assays are…
read more here.
Keywords:
tdo2;
liver cytosol;
development mass;
multiple species ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Trends in pharmacological sciences"
DOI: 10.1016/j.tips.2017.11.007
Abstract: Indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase 2 (TDO2) catalyze the commitment step of the kynurenine (KYN) metabolic pathway. Traditionally the immunosuppressive effect of IDO1 has been attributed mainly to reduced levels of tryptophan, which…
read more here.
Keywords:
tdo2;
tdo2 kyn;
targeting ido1;
cancer ... See more keywords
Photo by nci from unsplash
Sign Up to like & get
recommendations!
1
Published in 2021 at "BioMed Research International"
DOI: 10.1155/2021/4708439
Abstract: Background Tryptophan-2,3-dioxygenase (TDO2) converts tryptophan into kynurenine in the initial limiting step of the kynurenine pathway. During the past decade, the overexpression of TDO2 has been found in various human tumors. However, the role of…
read more here.
Keywords:
hepatocellular carcinoma;
cell proliferation;
tdo2;
expression ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Disease Markers"
DOI: 10.1155/2022/5447017
Abstract: Background Tryptophan 2,3-dioxygenase (TDO) encoded by TDO2, a rate-limiting enzyme in the kynurenine pathway, catabolizes tryptophan to kynurenine, evades immune surveillance, and promotes tumor growth. Although accumulating evidence suggests a crucial role of TDO2 during…
read more here.
Keywords:
tdo2;
prognosis;
pancancer analysis;
expression ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-21-0680
Abstract: Inactivation of the adenomatous polyposis coli (APC) is common across many cancer types and serves as a critical initiating event in most sporadic colorectal cancers (CRC). APC-deficiency activates WNT signaling which remains an elusive target…
read more here.
Keywords:
tdo2;
synthetic essentiality;
cancer;
tryptophan dioxygenase ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Molecules"
DOI: 10.3390/molecules24234346
Abstract: Cancers express tryptophan catabolising enzymes indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO2) to produce immunosuppressive tryptophan metabolites that undermine patients’ immune systems, leading to poor disease outcomes. Both enzymes are validated targets for cancer…
read more here.
Keywords:
ido1;
tdo2;
dioxygenase ido1;
indoleamine dioxygenase ... See more keywords
Photo by nci from unsplash
Sign Up to like & get
recommendations!
2
Published in 2022 at "International journal of oncology"
DOI: 10.3892/ijo.2022.5362
Abstract: Liver cancer is a malignant cancer phenotype for which there currently remains a lack of reliable biomarkers and therapeutic targets for disease management. Tryptophan 2,3‑dioxygenase (TDO2), a heme‑containing polyoxygenase enzyme, is primarily expressed in cells of…
read more here.
Keywords:
tdo2;
liver cancer;
cancer cell;
cell migration ... See more keywords